Subhashis Banerjee
- Immunology top 1%
- Rheumatology top 1%
- Dermatology top 0.5%
- Oncology top 5%
- Hematology top 2%
- Co-authors
- Gregory S. CameronDaniel BraunEmily Edson‐HerediaLinda LiClaus ZachariaeCraig L. LeonardiRobert MathesonDiamant Thaçi
- Topics
- Psoriasis: Treatment and Pathogenesis (46 papers)Cytokine Signaling Pathways and Interactions (19 papers)Autoimmune Bullous Skin Diseases (13 papers)
- Cited by
- ImmunologyDermatologyRheumatology
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Subhashis Banerjee
60 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Immunology 1.8k
- Rheumatology 770
- Dermatology 678
- Oncology 585
- Hematology 357
Countries citing papers authored by Subhashis Banerjee
This map shows the geographic impact of Subhashis Banerjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhashis Banerjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhashis Banerjee more than expected).
Fields of papers citing papers by Subhashis Banerjee
This network shows the impact of papers produced by Subhashis Banerjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhashis Banerjee. The network helps show where Subhashis Banerjee may publish in the future.
Co-authorship network of co-authors of Subhashis Banerjee
This figure shows the co-authorship network connecting the top 25 collaborators of Subhashis Banerjee. A scholar is included among the top collaborators of Subhashis Banerjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhashis Banerjee. Subhashis Banerjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 1 | |
| 3 | 27 | |
| 4 | 35 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 6 | |
| 13 | 12 | |
| 14 | 1 | |
| 15 | 22 | |
| 16 | Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritisbreakdown → | 134 |
| 17 | Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trialbreakdown → | 219 |
| 18 | 17 | |
| 19 | Efficacy and Safety of a Potent and Highly Selective Oral Tyrosine Kinase 2 Inhibitor, BMS-986165, in Patients with Moderate-to-Severe Plaque Psoriasis: A Phase II, Randomized, Placebo-Controlled Trial | 1 |
| 20 | 30 |
About Subhashis Banerjee
Subhashis Banerjee is a scholar working on Immunology, Pathology and Forensic Medicine and Rheumatology, having authored 62 papers that have together received 2.6k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (46 papers), Cytokine Signaling Pathways and Interactions (19 papers) and Autoimmune Bullous Skin Diseases (13 papers). The work is most often cited by research in Immunology (1.8k citations), Dermatology (678 citations) and Rheumatology (770 citations). Subhashis Banerjee has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Gregory S. Cameron, Daniel Braun, Emily Edson‐Heredia, Linda Li, Claus Zachariae, Craig L. Leonardi, Robert Matheson, Diamant Thaçi, Kim Papp and Akimichi Morita. Their work appears in journals such as New England Journal of Medicine, The FASEB Journal and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.